Human CCL15/MIP-1 delta Antibody, R&D Systems™

CCL15/MIP-1 delta

Monoclonal

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

chemokine (C-C motif) ligand 15, Chemokine CC-2, HCC-2, HCC-2Lkn-1, leukotactin 1, Leukotactin-1, LKN1, LKN-1, Macrophage inflammatory protein 5, MIP1 delta, MIP-1 delta, MIP5, MIP-5, MIP-5MIP-1d, Mrp-2b, NCC-3, NCC-3MIP-1D, NCC3MRP-2B, new CC chemokine 3, SCYA15member 15, Small-inducible cytokine A15

Mouse

Protein A or G purified from ascites

RUO

6359

Reconstitute at 0.5 mg/mL in sterile PBS.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG1

Western Blot, Neutralization

88119

Western Blot 1 ug/mL, Neutralization 5-20 ug/mL

Q16663

CCL15

E. coli-derived recombinant human CCL15/MIP-1 delta Ser46-Ile113 Accession # Q16663

25 μg

Primary

Detects human CCL15/MIP-1 delta in direct ELISAs and Western blots. In direct ELISAs, no cross-reactivity with recombinant human CCL1, 2, 3, 4, 5, 7, 8, 11, 13, 14, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, recombinant mouse CCL1, 2, 3, 4, 5, 6, 7, 9, 11, 12, 17, 19, 20, 21, 22, 24, 25, or recombinant rat CCL20 is observed.

Human

Purified